Artificial Intelligence
Q&A: Alex Zhavoronkov on Cognitive Enhancement, Anti-Aging, and AI Drug Development
Interviewed by William Leonard Pickard Alex Zhavoronkov, PhD, is Founder and CEO of Insilico Medicine, a leading clinical stage biotechnology company developing next-generation artificial intelligence and robotics platforms for drug discovery, with headquarters in Cambridge, MA…
Q&A: Alex Zhavoronkov on Cognitive Enhancement, Anti-Aging, and AI Drug Development

